News >

Sequencing Challenges Emerge in Myeloma After Recent Approvals

Ellie Leick
Published: Tuesday, Nov 26, 2019

Sham Mailankody, MBBS, a medical oncologist at Memorial Sloan Kettering Cancer Center

Sham Mailankody, MBBS

A number of novel agents alone and in combination have become available for patients with multiple myeloma in recent years, with several more on the horizon, explained Sham Mailankody, MBBS, adding that the surge of therapies poses sequencing challenges.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication